Welcome to our dedicated page for Ulta Beauty SEC filings (Ticker: ULTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ulta Beauty filings document the regulatory record for a Delaware operating company whose common stock trades on the Nasdaq Global Select Market under ULTA. Material-event reports cover financial results, guidance releases, retail partnership disclosures, executive leadership changes, board appointments and executive severance arrangements.
Proxy materials describe annual meeting matters, director elections, board committee structure, executive compensation, equity awards and pay-versus-performance disclosures. The filing record also provides formal disclosure of governance practices, officer compensation arrangements, registered securities and other corporate actions tied to Ulta Beauty’s specialty beauty retail business.
Smith Mike C. reported acquisition or exercise transactions in this Form 4 filing.
Ulta Beauty director Mike C. Smith received an equity grant as part of his compensation. He was awarded 404 shares of Ulta Beauty common stock in the form of restricted stock units at no cash cost, increasing his direct holdings to 2,667 shares.
The 404 restricted stock units will vest 100% on June 10, 2027, meaning the shares are delivered only if he remains eligible through that date. This is a routine, compensation-related award rather than an open-market stock purchase or sale.
Ruiz Gisel reported acquisition or exercise transactions in this Form 4 filing.
Ulta Beauty director Gisel Ruiz reported a new equity grant tied to her board service. She received 404 restricted stock units (RSUs), each linked to one share of Ulta Beauty common stock. The grant is deferred until her retirement or termination from the Board, and remains subject to vesting requirements.
Following this grant, Ruiz directly holds 787 RSUs and 1,363 shares of Ulta Beauty common stock. RSUs are a form of stock-based compensation that can align a director’s interests with long-term shareholder value because they typically settle in shares at a future date once vesting conditions are met.
Ulta Beauty director Lorna Nagler received a compensation-related equity grant. She was awarded 404 shares of Ulta Beauty common stock in the form of restricted stock units at no cash cost, classified as a grant or award acquisition. After this grant, she directly holds 7,768 common shares. The restricted stock units vest 100% on 6/10/2027, meaning she will receive the underlying shares on that date if vesting conditions are met. This is a routine equity award rather than an open-market stock purchase or sale.
MRKONIC GEORGE R JR reported acquisition or exercise transactions in this Form 4 filing.
Ulta Beauty director George R. Mrkonic Jr. received a grant of 404 restricted stock units of common stock, which vest 100% on June 10, 2027. After this equity award, his directly held common stock position reported in this filing totals 2,787 shares.
LITTLE PATRICIA A reported acquisition or exercise transactions in this Form 4 filing.
Ulta Beauty director Patricia A. Little received a grant of 404 restricted stock units (RSUs) tied to Ulta Beauty common stock. She has elected to defer receipt of these RSUs until her retirement or termination from the Board of Directors, subject to vesting requirements. Following this grant, she holds 1,670 RSUs and 1,765 shares of common stock directly.
Landry Stephenie Lee reported acquisition or exercise transactions in this Form 4 filing.
Ulta Beauty director Stephenie Lee Landry received an equity grant. She was awarded 404 shares of common stock as a grant or award, reported at a price of $0.00 per share, which is typical for stock-based compensation. This award represents 404 restricted stock units that vest 100% on June 10, 2027.
After this grant, she owns 681 shares of Ulta Beauty common stock directly. Because this is a compensation-related grant rather than an open-market purchase or sale, it mainly reflects ongoing director compensation rather than a change in personal investment stance.
Halligan Catherine Ann reported acquisition or exercise transactions in this Form 4 filing.
Ulta Beauty director Catherine Ann Halligan received an equity award. She was granted 404 shares of Ulta Beauty common stock in the form of restricted stock units, which vest 100% on June 10, 2027. After this grant, she holds 2,464 shares of common stock directly.
Ulta Beauty director Kelly E. Garcia received an equity grant of 404 shares of Ulta Beauty common stock on June 10, 2026. The shares were awarded as restricted stock units, which vest 100% on June 10, 2027, meaning they fully convert to shares on that date.
Following this grant, Garcia directly holds a total of 2,150 shares of Ulta Beauty common stock. The grant carried a stated price of $0.00 per share, reflecting that it is a compensation award rather than an open-market purchase.
Brok Martin reported acquisition or exercise transactions in this Form 4 filing.
Ulta Beauty, Inc. director Martin Brok received an equity award of 404 shares of Common Stock in the form of restricted stock units. The units were granted at no cash cost and will vest 100% on June 10, 2027. Following this award, he directly holds 1,681 shares.
Ulta Beauty, Inc. reported results from its 2026 annual stockholders meeting. Stockholders approved the new 2026 Incentive Award Plan, under which up to 5,001,201 shares of common stock may be issued, including 3,500,000 newly authorized shares and 1,501,201 shares carried over from the prior plan. Investors also approved amendments to the certificate of incorporation to add officer exculpation provisions and specify Delaware and U.S. federal courts as exclusive forums for certain legal actions. All director nominees were elected, Ernst & Young LLP was ratified as auditor for fiscal 2026, and stockholders supported executive compensation in an advisory vote.